|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||25.36 mL||126.78 mL||253.56 mL|
|0.5 mM||5.07 mL||25.36 mL||50.71 mL|
|1 mM||2.54 mL||12.68 mL||25.36 mL|
|5 mM||0.51 mL||2.54 mL||5.07 mL|
*The above data is based on the productmolecular weight 394.38. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||PF-04880594, PF04880594, PF 04880594|
LGX818 is an orally available Raf kinase inhibitor with potential antineoplastic activity.
B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 uM and 2 nM for A375 proliferation and A375 p-ERK respec…
AZ628 is a RAF inhibitor with IC50 values: ca 30 nM for BRAF V600E and wild-type CRAF and 100 nM for wild-type BRAF.
MLN 2480 is an oral, selective pan-Raf kinase inhibitor in chinical trials.
HG6-64-1 is a potent and selective B-Raf and mutant B-Raf inhibitor; more information can be found in Patent WO 2011090738.
RO5126766, also known as CH5126766, is a protein kinase inhibitor specific for the Raf and MEK mitogen-activated protein kinases (MAPKs) wi…
RAF265 (CHIR-265) is an oral, highly selective RAF and VEGFR kinase inhibitor, which is to control or normalize VEGFR-2 along with the inhib…